Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
As a result of the court ruling, this marks the end of the Food and Drug Administrations (FDA) enforcement discretion as follows: Small-scale compounders (i.e., 503A facilities), licensed by individual states and physician compounding, must stop producing compounded tirzepatide immediately
Nutr Neurosci 8:6789
Typical escalation for tirzepatide drops Tirzepatide escalation follows a similar pattern but with different milligram targets
(PubMed) Ravn-Haren G, Krath BN, Overvad K, et al
Compare total cost and payment timing
Talk to your prescriber first
US$ 22.79
US$ 21.91
US$ 27.11
US$ 20.34
US$ 26.29
